Valneva lifts EMA’s temporary restriction on use of chikungunya vaccine IXCHIQ in elderly
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
The company has confirmed that the deceased are 39
mRNA-1010 demonstrated superior relative vaccine efficacy
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
If approved, linerixibat could address high unmet medical need of patients living with cholestatic pruritus (relentless itch) and related sleep interference
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Subscribe To Our Newsletter & Stay Updated